The US pharmaceutical company Moderna said Friday it will develop a booster shot against the new Omicron variant of the coronavirus.
It is one of three strategies the company is working to address the new threat, including a higher dose of its existing vaccine, Moderna said.
“The mutations in the Omicron variant are concerning and for several days, we have been moving as fast as possible to execute our strategy to address this variant,” said Moderna CEO Stephane Bancel.
Moderna says Covid vaccine durable for at least six months
© 2021 AFP
Moderna says it will develop booster shot for new COVID variant (2021, November 27)
retrieved 27 November 2021
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
This blog is for information purposes only. The content is not intended as medical advice, diagnosis, or treatment. Should you have a medical or dermatological problem, please consult with your physician. None of the information or recommendations on this website should be interpreted as medical advice.
All product reviews, recommendations, and references are based on the author’s personal experience and impressions using the products. All views and opinions are the author’s own.
This blog post may contain affiliate links. An affiliate link means we may earn a commission if you click on a link and make a purchase, without any extra cost to you.
Please see our Disclaimer for more information.